A sign for the Food and Drug Administration is displayed outside their offices in Silver Spring, Md., on Dec. 10, 2020. The maker of an unproven drug intended to prevent premature births says it will voluntarily remove the product from the U.S. market, after regulators signaled plans to follow through on a long-delayed effort to force it from the market. The announcement late Tuesday, March 7, 2023, from Covis Pharma comes nearly four years after the company’s drug, Makena, failed to show a benefit in helping mothers carry their pregnancies to term. (AP Photo/Manuel Balce Ceneta, File)
Featured Photo Galleries
